EKTERLY
sebetralstat
Listed by KalVista Pharmaceuticals Ltd
- Strength
- 300 mg/1
- Form
- Tablet
- Route
- Oral
- Class
- Plasma Kallikrein Inhibitor
What it contains
- Sebetralstat 300 mg/1
FDA record
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Plasma Kallikrein Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 82928-300 |
| FDA application | NDA219301 |
| RxNorm concept | 2717949 |
| Package sizes listed | 2 |
| Marketed since | July 2025 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.